Thursday, October 29, 2020

Russia Receives Renewed Approval For COVID-19 Vaccine Trials In India

The Russian Direct Investment Fund (RDIF) and Dr Reddy's Laboratories Ltd have received renewed approval to conduct late-stage clinical trials in India...

Glenmark Pharma launches pulmonary fibrosis treatment drug in India

Glenmark Pharma on Wednesday announced the launch of its generic version of Nintedanib (NINDANIB), used for the treatment of pulmonary fibrosis, in...

Vaccine Expected Early Next Year, From More Than One Source: Minister

A vaccine against coronavirus is expected to be available in India by early next year and there could be vaccines from more...

Johnson & Johnson Pauses Covid Vaccine Trial As Participant Falls Ill

Johnson & Johnson said Monday it had temporarily halted its Covid-19 vaccine trial because one of its participants had become sick.

Coronavirus Update: India Logged Over 70,000 New Cases On Friday

India recorded 70,496 fresh cases of coronavirus and 964 deaths on Friday, taking the total number of COVID-19 cases to 69 lakh,...

“Plan To Cover 25 Crore By Next July”: Health Minister On Covid Vaccine

The government plans to provide Covid vaccines to around 25 crore (250 million) people - of the country's 130 crore (1.3 billion)...

Researchers Develop New Covid Test That Doesn’t Use Scarce Reagents

Scientists have developed a new method of testing for COVID-19 that doesn't make use of key reagents but still delivers an accurate...

Covid vaccine may be available in India by January 2021, but with challenges: AIIMS...

All India Institute of Medical Sciences (AIIMS) Director Dr Randeep Guleria said an effective Covid-19 vaccine can be expected in India by...

Moderna’s Coronavirus Vaccine Won’t Be Ready Before US Elections: Report

US biotech firm Moderna won't seek an emergency use authorization for its coronavirus vaccine before November 25, its CEO told the Financial...

“Don’t Agree With Rs 80,000 Crore Figure For COVID Vaccine Distribution”: Centre

The Union Health Ministry has said it does not agree with the ₹ 80,000 crore figure cited by Adar Poonawalla, CEO of...

Stay connected


Latest article

Top Court Lists Hearing On Centre’s Interest Waiver Plan

The Supreme Court today adjourned a hearing in the matter of waiving "interest on interest" on loans up to ₹ 2 crore,...

Amazon Prepares for Holiday Sales Amid COVID-19 Challenges

Amazon on Thursday will announce its latest financial results, and Wall Street wants to know if it can keep up with shoppers'...

India Covid Tally Nears 80 Lakh, 43,893 New Cases; 508 Deaths In A Day

With a positivity rate of 4.1 per cent, India's daily cases increased by 43,893 in the last 24 hours, taking the country's...